IL33 and breast carcinoma: IL-33’s role in tumorigenesis was first identified in breast cancer [14,15], and more recently, omics studies and single-cell sequencing have demonstrated that, upon stimulation by IL-33 and IL-5 as well as CD4+ T cells, eosinophils could enhance CD8+ T-cell activation [16].